Science


European Court Invalidates Harvard Biotech Patent in Three Countries

A top European court ruled against Harvard last week in a patent dispute against biotech company NanoString Technologies, invalidating one of the University’s two disputed patents in three European countries.


Cerebellum Only Necessary for Some Muscle Memory, Harvard Researchers Find

In an August study, researchers at the Harvard School of Engineering and Applied Sciences discovered a new distinction between long and short-term motor memories — a class of memories developed through repeated physical movements.


‘Share the Universe’: Harvard Astronomy Club Holds Rare Comet Viewing

Dozens of students gathered at Harvard’s Loomis-Michael Observatory on Thursday and Friday for a rare viewing of Comet Tsuchinshan-ATLAS, a “naked-eye visible comet” that researchers say is unlikely to return for at least 80,000 years.


Harvard’s Wyss Institute Gives Startup License to Use Newly-Developed Biomaterials

Attivare Therapeutics, a startup founded by researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering, received a license from the Wyss Institute to use biomaterials developed at Harvard to create treatments for tumors that do not respond to existing immunotherapies.


Harvard Museum of Natural History Hosts National Fossil Day

The Harvard Museum of Natural History welcomed visitors on Sunday for its third annual National Fossil Day event since the Covid-19 pandemic, allowing children and adults to learn about paleontology by interacting with artifacts from the museum's collections.


Brigham and Women's Hospital Researchers Find Nasal Spray Protects Against Respiratory Illnesses

Researchers found that a drug-free nasal spray protected against airborne respiratory illnesses — including Covid-19, influenza, viruses, and pneumonia — in a preclinical study published by Harvard Medical School-affiliated Brigham and Women’s Hospital on Sept. 24.


Canadian Biotech Company to Supply MDMA for McLean Hospital Clinical Trial

Toronto-based MDMA manufacturer PharmAla Biotech signed a contract to supply researchers at McLean Hospital, an HMS-affiliated psychiatric teaching hospital, with the drug for a pending clinical trial, PharmAla announced in a Oct. 2 press release.


HMS Researchers Introduce AI Tool for Drug Repurposing

Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model which is able to suggest new treatment applications of existing drugs using neural networks.


Former CDC Director Rochelle Walensky To Headline 2024-25 Belfer Center Senior Fellows Cohort

Rochelle P. Walensky — who led the Center for Disease Control and Prevention during the Covid-19 pandemic — will headline the 2024-25 cohort of senior fellows at the Belfer Center for Science and International Affairs at the Harvard Kennedy School.


HMS Professor Wins Prestigious Lasker-DeBakey Award for Work on GLP-1

Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on the glucagon-like peptide-1 (GLP-1), the Lasker Foundation announced last Thursday.


Developers Press Pause on New Allston Labs

Real estate firms are hitting the breaks on laboratory development in Allston. A nearly billion-dollar project from National Development to redevelop a TV studio at 1170 Soldiers Field Rd. to build new offices, lab space, and housing is not moving forward, according to a person familiar with the process.


David Charbonneau, Professor in Search of Planets in Outer Space, Wins $1 Million Kavli Prize

Harvard Astrophysics professor David Charbonneau won the 2024 Kavli Prize in Astrophysics in June, sharing a $1 million prize with MIT professor Sara Seager for their discoveries of exoplanets — planets located outside Earth’s solar system.


Harvard Kennedy School Public Impact Analytics Science Lab Receives $3 Million From DOD

The Public Impact Analytics Science Lab at the Harvard Kennedy School received a nearly $3 million grant from the U.S. Department of Defense on Sept. 1 for a project that will leverage artificial intelligence to create personalized treatments for melanoma.


‘Hyped Just About Right’: How the AI Boom is Reshaping Research at Harvard

As ChatGPT took the world by storm, many raised concerns about how it might help students cheat themselves out of learning. But a year and a half later, AI is changing the work of professors perhaps even more.


1-25 of 1082
Older ›
Oldest »